2Piffko J,Bankfalvi A,Klauke K,et al. Unaltered strong immunohis-tochemical expression of CD44v6 and CD44v5 isoforms during de-velopment and progression of oral squamous cell caxcinomasf J] . 0-ral Pathol Med, 1996,25(9) :502 -506.
3Shih - Chun Lee,Homg - Jyh Ham. Prognostic significance ofCD44v5 expression in human thymic epithelial neoplasmsf J]. So-ciety Thoracic Surgeons,2003 ,76 :213 -218.
4Lee LN,Kuo SH,Lee YC,et al. CD44 splicing pattern is associatedwith disease progression in pulmonary adenocarcinoma [ J]. J For-mos Med Assoc,2005,104(8) :541 -548.
5Kim DY,Kim HR,Shim JH,et al. Significance of serum and tissuecarcinoma bryonic antigen for the prognosis of gastrtic carcinomapatients[ J]. Surg Oncol,2000,74(3) :185 - 192.
6Yasasever V,Tas F,Duranyildiz D,et al. Serum levels of the solu-ble adhesion molecules in patients with malignant melanoma [ J ].Pathol Oncol Res,2000,6(1) :42 -45.
7Marhaba R, Zoller M. CD44 in cancer progression: adhesion, mi-gration and growth regulation [ J]. Mol Histol,2004,35(3) :211-213.
8Sebastian Mayer,Axel zur Hausen,Dirk Otto Watermann,et al. In-creased soluble CD44 concentrations are associated with largertumor size and lymph node metastasis in breast cancer patients[J]. J Cancer Res Clin Oncol,2008,134:1229 - 1235.
9Toshirou Kawano,Shunsuke Yanoma. Evaluation of soluble adhe-sion molecules CD44 ( CD44st,CD44v5 , CD44v6 ) , ICAM - 1,and VC AM — 1 as tumor markers in head and neck cancer [J].Am J Otolaryngol Head and Neck Med and Sur,2005 ,26 :308 -.
10Kuo MYP, Cheng SJ, Chen HM, et al. Expression of CD44s,CD44v5,CD44v6 and CD44v7 -8 in betel quid chewing - asso-ciated oral premalignant lesions and SCCs in Taiwan[ J]. J OralPathol Med,1998,27(9) :428 -433.
